Ketamine Therapy for Treatment-Resistant Depression in Palm Beach Gardens

Ketamine for TRD | PBG

When depression symptoms persist despite trying at least two antidepressants at adequate doses and durations, clinicians may diagnose treatment-resistant depression (TRD). This condition can significantly affect daily functioning, emotional well being, relationships, and quality of life. For adults exploring ketamine for TRD Palm Beach Gardens, Allay Health and Wellness provides individualized evaluations and treatment options for patients who have not experienced sufficient improvement with conventional antidepressant medications.

Allay Health and Wellness offers two distinct approaches: IV ketamine infusion therapy, which is prescribed off label for depression, and Spravato (esketamine) nasal spray, an FDA approved treatment for eligible adults with TRD. Both require clinical assessment, supervised administration, and appropriate monitoring. Although some patients experience improvements in depressive symptoms, treatment responses vary, and neither option guarantees remission. Choosing between these approaches depends on several factors, including your diagnosis, previous treatment history, current medications, medical conditions, insurance coverage, and individual clinical needs. This guide explains how ketamine for TRD Palm Beach Gardens works, the differences between IV ketamine and Spravato, eligibility considerations, potential risks, and what patients can expect during treatment at Allay Health and Wellness.

What Is Treatment Resistant Depression?

Treatment resistant depression (TRD) generally refers to a major depressive episode that has not responded adequately to at least two appropriate antidepressant trials at sufficient doses and durations. Many patients have tried SSRIs, SNRIs, atypical antidepressants, medication augmentation strategies, or treatments such as ECT and TMS before exploring ketamine for TRD Palm Beach Gardens. A comprehensive evaluation helps determine whether previous treatments were adequate and whether other medical or psychiatric factors may be contributing to persistent symptoms.

TRD can intensify the challenges associated with major depression, including prolonged symptoms, impaired daily functioning, and increased suicide risk. When conventional antidepressants provide insufficient relief, clinicians may consider treatments that act through different biological pathways. This has contributed to growing clinical interest in ketamine based therapies for selected patients with difficult to treat depression. Ketamine primarily acts as an NMDA receptor antagonist, influencing glutamate signaling rather than relying on the mechanisms associated with conventional antidepressants. Research suggests that downstream changes involving brain derived neurotrophic factor (BDNF) and synaptic plasticity may contribute to its antidepressant effects, although these mechanisms are not fully understood. Some patients experience improvement within hours or days, while others respond more gradually or not at all. At Allay Health and Wellness, adults considering ketamine for TRD Palm Beach Gardens can undergo an individualized evaluation to discuss potential treatment options, including off label IV ketamine and FDA-approved Spravato (esketamine), along with their respective benefits, limitations, and safety considerations.

IV Ketamine Infusions for TRD: What You Need to Know

Intravenous ketamine has been used off-label for the treatment of major depressive disorder and treatment resistant depression since the early 2000s, with a substantial body of peer-reviewed research supporting its antidepressant effects. At Allay Health, IV ketamine infusions are administered to TRD patients in Palm Beach Gardens under the direct supervision of licensed clinical staff, following a thorough medical intake and psychiatric evaluation.

Important regulatory note: IV ketamine is not FDA approved for any psychiatric indication. Its use for TRD, MDD, PTSD, anxiety, or any other mental health condition is entirely off label. This means IV ketamine is used at the clinical judgment of a licensed provider based on the weight of available evidence, but it has not undergone the FDA approval process for psychiatric use. Allay providers discuss this distinction with every patient during the informed consent process. Off label use of FDA approved medications is a legal and common medical practice, but patients pursuing ketamine for TRD Palm Beach Gardens deserve full transparency about the regulatory status of any treatment they receive. A standard IV ketamine induction course consists of six infusions over two to three weeks, each lasting 40 to 60 minutes. Some patients experience transient perceptual effects during infusion that resolve when the infusion ends. Maintenance infusions may follow the induction series based on clinical response. The decision to pursue IV ketamine as ketamine for TRD Palm Beach Gardens care is made collaboratively based on diagnosis, history, and patient preference.

Spravato (Esketamine) for TRD: FDA Approved Pathway

Spravato (esketamine nasal spray, manufactured by Janssen Pharmaceuticals) is the first FDA approved ketamine based treatment for psychiatric indications. It carries two distinct FDA approvals: treatment resistant depression in adults, and major depressive disorder with acute suicidal ideation or behavior in adults. As of 2025, the FDA has also approved Spravato as a monotherapy for TRD, expanding its use beyond the original adjunctive indication.

Regulatory clarity: Unlike IV ketamine, Spravato is not off label for TRD, it is specifically approved for this indication. Its use for other conditions, including PTSD or anxiety, would be off label. Allay providers are precise about this distinction. Because Spravato can cause dissociation and sedation and carries a risk of misuse, the FDA’s REMS safety requirements restrict its administration to certified healthcare settings. Patients must self administer each dose under professional supervision and remain on site for at least two hours of monitoring. As a REMS certified facility, Allay Health and Wellness incorporates these safeguards into its clinician supervised Spravato treatment in Palm Beach Gardens, with appropriate patient assessment, supervised administration, and post treatment observation.

For patients pursuing ketamine for TRD Palm Beach Gardens care who have qualifying diagnoses and meet insurance eligibility criteria, Spravato offers a significant practical advantage over IV ketamine: it is covered by many major insurance plans, including Medicare Part B and several commercial carriers. IV ketamine, as an off label treatment, is typically not covered by insurance and is paid out of pocket. The Allay team assists patients with prior authorization paperwork and benefits verification for Spravato coverage.

IV Ketamine vs. Spravato: Choosing the Right TRD Pathway

Both IV ketamine and Spravato are available at Allay Health for eligible patients with treatment resistant depression. Understanding the key differences helps patients and providers make the right clinical choice together. The following comparison reflects current evidence, regulatory status, and practical clinical considerations for ketamine for TRD Palm Beach Gardens patients at Allay. Understanding these differences is an essential part of the clinical decision-making process.

• FDA approval status: Spravato is FDA approved for TRD and MDD with acute suicidal ideation; IV ketamine is off label for all psychiatric indications including TRD.
• Administration: IV ketamine is administered through an intravenous infusion, typically over 40 to 60 minutes. Spravato is a self administered nasal spray, used under clinical supervision at a REMS certified facility with a required two hour post dose monitoring period.
• Insurance coverage: Spravato is covered by Medicare Part B and many commercial insurance plans for qualifying patients with TRD. IV ketamine is not covered by insurance and is self pay.
• Evidence base: Both have substantial clinical evidence. IV ketamine has a longer research history; Spravato has a larger Phase III trial dataset. Neither is definitively superior for all patients.
• Monitoring requirements: Both require on site clinical monitoring. Spravato REMS mandates a minimum two hour post dose observation period.
• Typical course: IV ketamine induction is six infusions over two to three weeks, followed by maintenance as needed. Spravato induction is typically twice weekly for four weeks, then weekly for four weeks, then every one to two weeks as maintenance.

The right choice depends on diagnosis, coverage, medical history, and clinical judgment, discussed at your Allay intake consultation.

Who Qualifies for Ketamine Therapy for TRD at Allay?

Ketamine for TRD at Allay Health in Palm Beach Gardens is available to adults 18 and older who meet clinical criteria. Qualification involves a comprehensive intake evaluation that reviews psychiatric history, prior treatment trials, current medications, and medical history. General criteria for ketamine for TRD Palm Beach Gardens consideration include a confirmed diagnosis of major depressive disorder with at least two adequate antidepressant treatment failures. For Spravato, insurance typically requires documentation of TRD per FDA-label criteria. Patients with MDD and acute suicidal ideation may qualify under the MDD with SI indication.

Medical factors reviewed include: uncontrolled hypertension, active psychosis, history of ketamine abuse or dissociative disorder, certain liver conditions, and pregnancy or breastfeeding. These require careful clinical evaluation; they are not automatic exclusions in all cases. Current medications are reviewed at intake. Patients on MAOIs, lamotrigine, or high dose benzodiazepines may require protocol discussion. Patients are never asked to stop any medication without coordination with their prescribing provider. The intake process at Allay includes a clinical interview, review of prior treatment records when available, and a discussion of goals, expectations, and informed consent for the specific treatment pathway recommended. Patients who are not good candidates for ketamine are referred to appropriate alternative resources. The National Alliance on Mental Illness provides additional background on depression treatment options for patients and families.

What to Expect: Your First Appointment at Allay for TRD

Walking into a ketamine clinic for the first time can feel unfamiliar. Allay’s clinical team makes understanding the process a priority for every patient pursuing ketamine for TRD Palm Beach Gardens, from first consultation through the end of the induction series. Here is what to expect from your first visit through your initial treatment series. Your first appointment is an intake and evaluation session. You will complete a health history intake form and meet with a member of Allay’s clinical team for a psychiatric and medical evaluation. This session is not a treatment session; it is a comprehensive clinical review to determine whether ketamine therapy is appropriate for your situation, and if so, which pathway (IV ketamine or Spravato) is recommended.

If you are deemed a candidate, the next step is protocol planning: insurance verification and prior authorization for Spravato, or scheduling and pre infusion instructions for IV ketamine. Both pathways involve signed informed consent addressing regulatory status. Your first treatment session includes pre-session vitals, administration in a monitored clinical space, and a post treatment observation period before discharge. You will not be permitted to drive on treatment days and should arrange transportation. Following your induction series, a clinical review assesses your response and plans next steps. Allay coordinates with your existing psychiatrist or prescriber throughout.

FAQs About Ketamine for TRD Palm Beach Gardens

1. How quickly does ketamine work for treatment resistant depression?
   Some patients experience improvements in depressive symptoms within hours or days of receiving ketamine, although responses vary considerably. Adults exploring ketamine for TRD Palm Beach Gardens should understand that improvement is not guaranteed, and some patients may require multiple sessions before their response can be evaluated. Allay Health and Wellness assesses individual progress throughout treatment.
2. Is ketamine a cure for treatment resistant depression?
   No. Ketamine is not a cure for treatment resistant depression (TRD). Research suggests it may reduce depressive symptoms in some patients who have not responded adequately to conventional treatments. However, benefits may be temporary, and additional treatment may be necessary. Ketamine is generally considered within a broader mental health care plan that may include psychotherapy and medication management.
3. Will insurance cover ketamine therapy for TRD?
   Insurance coverage depends on the treatment and individual policy. Spravato (esketamine) may be covered by Medicare or commercial insurance for eligible patients, subject to plan requirements and prior authorization. IV ketamine for depression is an off label treatment and is often self pay.
4. Can I continue my current antidepressants during ketamine therapy?
   Many patients continue prescribed antidepressants while receiving ketamine treatment, but medication decisions require individual clinical review. Spravato is FDA approved for treatment resistant depression either alone or alongside an oral antidepressant. Patients considering ketamine for TRD Palm Beach Gardens should disclose all medications, including benzodiazepines and other psychiatric prescriptions. Never change or discontinue medication without consulting your prescriber.
5. How many ketamine sessions will I need?
   Treatment frequency depends on the medication, clinical response, and individual needs. IV ketamine protocols sometimes involve six initial infusions over two to three weeks, although schedules vary. Spravato treatment commonly begins with twice weekly sessions for four weeks, followed by less frequent administration. Your provider will assess your response and discuss whether additional sessions are appropriate.
6. Does Allay offer both IV ketamine and Spravato?
   Yes. Allay Health and Wellness provides IV ketamine treatment and Spravato (esketamine) therapy for eligible patients. IV ketamine for depression is prescribed off label, while Spravato has FDA approved indications for certain depressive conditions. Patients researching ketamine for TRD Palm Beach Gardens can discuss their diagnosis, treatment history, medical suitability, and insurance considerations during an evaluation.
7. What should I do between ketamine sessions?
   Continue following your prescribed mental health treatment plan, including medication management and psychotherapy when recommended. Maintaining regular sleep, appropriate physical activity, and communication with your healthcare providers may support overall well being. Report any concerning symptoms or changes in mood to your treatment team. Follow post treatment instructions carefully, including restrictions on driving after ketamine or Spravato administration.

Schedule a TRD Consultation at Allay Health in Palm Beach Gardens

If you have tried multiple antidepressants without adequate improvement, exploring ketamine for TRD Palm Beach Gardens may be an appropriate next step. At Allay Health and Wellness, a consultation provides an opportunity to review your diagnosis, previous treatments, medical history, and individual health needs. The clinical team can explain the differences between off label IV ketamine and FDA approved Spravato (esketamine), including potential benefits, risks, and eligibility requirements.

Allay Health and Wellness serves adults in Palm Beach Gardens, Jupiter, North Palm Beach, Juno Beach, Tequesta, and surrounding Palm Beach County communities. Patients managing additional health concerns may also explore the clinic’s chronic pain management, hormone replacement therapy for men, women’s hormone therapy, IV therapy, or medical weight loss services. Each treatment requires an appropriate clinical evaluation. Understanding your options for treatment resistant depression can help you prepare for an informed discussion with your provider. To schedule a consultation for ketamine for TRD Palm Beach Gardens, call Allay Health and Wellness. Our Palm Beach Gardens office can discuss appointment availability, consultation requirements, and insurance related questions.

Allay Health and Wellness
11000 Prosperity Farms Rd, Suite 101
Palm Beach Gardens, FL 33410
Email: [email protected]
Phone: (561) 421-6444

Medical Disclaimer: The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. IV ketamine is not FDA-approved for any psychiatric indication; its use for treatment-resistant depression is off-label. Spravato (esketamine) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation in adults. Individual results vary and no specific outcome is guaranteed. Consult a qualified healthcare provider before beginning any new treatment. If you are experiencing a mental health crisis, call or text 988.

Reviewed by Nicholas Marino, MBA, Co-Founder and CEO, Allay Health and Wellness